Journal of Pediatric Care

Heparin-Induced Thrombocytopenia in Pediatrics Mini Review

The use of heparin has a potential risk of developing heparin-induced thrombocytopenia, which, although infrequent, is of great importance due to high morbidity and mortality that requires rapid diagnosis and timely treatment. A clinical case of a patient with dilated cardiomyopathy, with extracorporeal support is described, which is anticoagulated with heparin by protocol, presenting an adverse effect little reported in the literature such as heparin-induced thrombocytopenia requiring Fondaparinux with failure to start bivalirudin.

Author(s):

Andrea Carolina Zarate Vergara , María Alexandra Pérez Sotelo  and Irina Suley Tirado Pérez

Abstract | PDF

Share this